Table 1 Clinical characteristics of the study population undergoing RF-TC guided by SEEG procedures (n = 44)

Age at seizure onset (years)

44

13–50

28.6 (22.0–37.5)

Sex (male/female)

31/13

-

-

Duration of epileptic seizures (years)

0.1–39

6.5 (0.8, 11.3)

Seizure frequency (D/W/M)

10/13/21

-

-

Number of ASMs administration before RF-TC (n)

-

1–4

2 (1, 3)

Etiology of epilepsy

 Malformations of cortical development

4

-

-

 Polymicrogyria

1

-

-

 Focal cortical dysplasia

3

-

-

 Neurodevelopmental tumors

3

-

-

 Hippocampal sclerosis

12

-

-

 Cranial trauma

2

-

-

 Cerebrovascular disease

2

-

-

 Unspecified histology

6

-

-

 Unknown

9

-

-

Lateralization of epilepsy (Rs/Ls/Bi)

26/16/2

-

-

Lateralization of electrode implantation

 Right-sided

10

-

-

 Left-sided

6

-

-

Bilateral with right hemispheric predominance

16

-

-

Bilateral with left hemispheric predominance

12

-

-

SEEG monitoring duration (day)

-

3–15

7.5 (6.8, 11)

Number of electrodes implants (n)

-

4–12

7.7 ± 0.4

Follow-up time (month)

42

9–51

32 (13.5, 43.3)